X4 Pharmaceuticals (XFOR) Short Interest Ratio & Short Volume $3.92 +0.74 (+23.27%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.74 -0.19 (-4.72%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock X4 Pharmaceuticals Short Interest DataX4 Pharmaceuticals (XFOR) has a short interest of 1.02 million shares, representing 26.22% of the float (the number of shares available for trading by the public). This marks a 161.27% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 10.57 million shares to cover all short positions.Current Short Interest1,020,000 sharesPrevious Short Interest390,400 sharesChange Vs. Previous Month+161.27%Dollar Volume Sold Short$1.71 millionShort Interest Ratio1.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares11,410,000 sharesFloat Size3,890,000 sharesShort Percent of Float26.22%Today's Trading Volume3,258,510 sharesAverage Trading Volume10,566,333 sharesToday's Volume Vs. Average31% Short Selling X4 Pharmaceuticals? Sign up to receive the latest short interest report for X4 Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXFOR Short Interest Over TimeXFOR Days to Cover Over TimeXFOR Percentage of Float Shorted Over Time X4 Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,020,000 shares $1.71 million +161.3%26.2%1.2 $1.68 7/15/2025390,400 shares $573.89 thousand +34.3%10.2%0.6 $1.47 6/30/2025290,800 shares $552.52 thousand -40.0%5.1%0.7 $1.90 6/15/2025484,800 shares $1.37 million +22.2%12.6%2.3 $2.82 5/31/2025396,900 shares $1.34 million +27.1%10.3%2.5 $3.37 5/15/2025312,300 shares $943.15 thousand +7.4%8.1%2.9 $3.02 4/30/2025290,700 shares $1.25 million -96.7%7.6%3.4 $4.31 4/15/20258,800,000 shares $54.91 million +8.9%5.2%2.7 $6.24 3/31/20258,080,000 shares $1.91 million -6.5%4.8%2.3 $0.24 3/15/20258,640,000 shares $2.94 million -8.9%5.1%2.4 $0.34 Get the Latest News and Ratings for XFOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for X4 Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/20259,480,000 shares $3.75 million -14.3%5.7%2.3 $0.40 2/15/202511,060,000 shares $5.62 million -33.4%6.6%2.7 $0.51 1/31/202516,610,000 shares $11.63 million +22.6%N/A3.1 $0.70 1/15/202513,550,000 shares $6.25 million +1.4%N/A3.7 $0.46 12/31/202413,360,000 shares $9.80 million +1.2%N/A3.9 $0.73 12/15/202413,200,000 shares $8.85 million +5.6%N/A4.2 $0.67 11/30/202412,500,000 shares $4.91 million -3.4%N/A4.6 $0.39 11/15/202412,940,000 shares $5.22 million +13.3%N/A5.5 $0.40 10/31/202411,420,000 shares $5.71 million -9.8%N/A10.6 $0.50 10/15/202412,660,000 shares $7.05 million -6.6%N/A11.6 $0.56 9/30/202413,560,000 shares $9.08 million -0.4%N/A11.4 $0.67 9/30/2024370,900 shares $537.81 thousand -1.5%7.2%0.2 $1.45 9/15/202413,620,000 shares $9.67 million -10.6%N/A7.4 $0.71 9/15/2024376,600 shares $636.45 thousand +19.4%7.3%0.1 $1.69 8/31/202415,230,000 shares $10.66 million -0.9%N/A8 $0.70 8/31/2024315,500 shares $542.66 thousand -36.9%6.1%0.1 $1.72 8/15/202415,370,000 shares $9.72 million +4.4%N/A7.7 $0.63 8/15/2024499,900 shares $689.86 thousand +7.5%9.6%0.1 $1.38 7/31/202414,720,000 shares $11.78 million -10.8%N/A6.7 $0.80 7/31/2024464,900 shares $702.00 thousand -37.7%9.2%0.1 $1.51 7/15/202416,510,000 shares $11.71 million +19.0%N/A5.5 $0.71 7/15/2024745,900 shares $1.52 million +78.3%14.8%0.2 $2.04 6/30/202413,880,000 shares $8.05 million +16.4%N/A4.4 $0.58 6/30/2024418,300 shares $966.27 thousand +10.1%7.3%0.1 $2.31 6/15/202411,920,400 shares $12.16 million +0.3%N/A4.3 $1.02 6/15/2024380,100 shares $513.14 thousand +164.0%8.2%0.1 $1.35 5/31/202411,880,000 shares $12.00 million -2.7%N/A3.6 $1.01 5/31/2024144,000 shares $62.78 thousand +211.7%3.6%0.1 $0.44 5/15/202412,210,000 shares $11.92 million -7.4%N/A3.7 $0.98 5/15/202446,200 shares $24.22 thousand +974.4%1.5%0.2 $0.52A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 4/30/202413,190,000 shares $14.77 million +7.6%N/A4.2 $1.12 4/30/20244,300 shares $3.35 thousand -59.4%0.2%0.1 $0.78 4/15/202412,260,000 shares $15.33 million -0.6%N/A5.1 $1.25 4/15/202410,600 shares $7.69 thousand -47.5%0.4%0.6 $0.73 3/31/202412,330,000 shares $17.14 million -13.3%N/A5.8 $1.39 3/31/202420,200 shares $20.81 thousand -14.4%0.8%0.6 $1.03 3/15/202414,220,000 shares $13.19 million -1.3%N/A7.4 $0.93 3/15/202423,600 shares $24.31 thousand -37.4%1.0%0.4 $1.03 2/29/202414,400,000 shares $13.98 million +8.8%N/A8.1 $0.97 2/29/202437,700 shares $41.47 thousand -29.8%1.6%0.5 $1.10 2/15/202413,230,000 shares $12.52 million +3.4%N/A6.6 $0.95 2/15/202453,700 shares $62.83 thousand -33.3%2.3%0.6 $1.17 1/31/202412,800,000 shares $10.00 million +6.8%N/A6.1 $0.78 1/31/202480,500 shares $90.97 thousand +27.6%3.4%1 $1.13 1/15/202411,990,000 shares $9.83 million +3.2%N/A5.2 $0.82 1/15/202463,100 shares $78.88 thousand +102.2%2.7%0.7 $1.25 12/31/202311,620,000 shares $9.74 million -1.0%N/A5.1 $0.84 12/31/202331,200 shares $34.94 thousand -12.1%1.3%0.4 $1.12 12/15/202311,740,000 shares $8.38 million +2.8%N/A5.2 $0.71 12/15/202335,500 shares $42.96 thousand -33.2%1.5%0.4 $1.21 11/30/202311,420,000 shares $8.91 million -0.3%N/A6.2 $0.78 11/30/202353,100 shares $66.38 thousand -7.8%2.3%0.5 $1.25 11/15/202311,450,000 shares $9.00 million -0.5%N/A7.5 $0.79 11/15/202357,600 shares $65.09 thousand -26.7%2.5%0.5 $1.13 10/31/202311,510,000 shares $9.21 million +5.8%N/A5.5 $0.80 10/31/202378,600 shares $92.75 thousand +35.1%4.8%0.4 $1.18 10/15/202310,880,000 shares $9.70 million +2.5%N/A5.7 $0.89 10/15/202358,200 shares $68.68 thousand -61.1%3.6%0.2 $1.18 9/30/202310,620,000 shares $11.58 million -2.4%N/A5.2 $1.09 9/30/2023149,700 shares $164.67 thousand +156.8%9.2%0.5 $1.10 9/15/202310,880,000 shares $12.08 million +5.7%N/A4.9 $1.11 9/15/202358,300 shares $72.58 thousand +80.5%3.6%0.2 $1.25 8/31/202310,290,000 shares $13.17 million -6.8%N/A3.6 $1.28 8/31/202332,300 shares $40.38 thousand -34.9%2.1%0.1 $1.25 8/15/202311,040,000 shares $13.25 million -8.4%N/A3.3 $1.20 8/15/202349,600 shares $68.94 thousand +2,056.5%3.6%0.3 $1.39 7/31/202312,050,000 shares $21.57 million -11.2%N/A3.5 $1.79 7/31/20232,300 shares $5.59 thousand -70.9%0.2%0 $2.43 7/15/202313,570,000 shares $25.51 million -5.7%N/A3.7 $1.88 7/15/20237,900 shares $25.68 thousand -65.4%0.6%0 $3.25 6/30/202314,390,000 shares $27.92 million +57.4%N/A3.7 $1.94 6/30/202322,800 shares $71.59 thousand -26.9%1.7%0.1 $3.14 6/15/20239,140,000 shares $20.75 million +7.0%N/A2.3 $2.27 6/15/202331,200 shares $93.91 thousand -22.4%2.3%0.1 $3.01 5/31/20238,540,000 shares $17.34 million +189.5%N/A2.6 $2.03 5/31/202340,200 shares $103.31 thousand -23.9%3.1%0.2 $2.57 5/15/20232,950,000 shares $4.48 million -2.6%N/A1.1 $1.52 5/15/202352,800 shares $182.16 thousand +214.3%4.0%0.2 $3.45 4/30/20233,030,000 shares $4.45 million -14.2%N/A1.7 $1.47 4/30/202316,800 shares $57.79 thousand +1,427.3%1.3%0.1 $3.44A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 4/15/20233,530,000 shares $4.06 million +86.8%N/A2.6 $1.15 4/15/20231,100 shares $3.30 thousand -96.1%0.0%0.1 $3.00 3/31/20231,890,000 shares $1.64 million +10.5%N/A1.7 $0.87 3/31/202328,400 shares $9.09 thousand -15.5%0.2%0.6 $0.32 3/15/20231,710,000 shares $1.55 million +34.7%N/A2.1 $0.91 3/15/202333,600 shares $15.79 thousand +232.7%0.3%0.7 $0.47 2/28/20231,270,000 shares $1.19 million +22.1%N/A1.1 $0.94 2/28/202310,100 shares $4.85 thousand +87.0%0.1%0.2 $0.48 2/15/20231,040,000 shares $1.04 million -3.7%N/A0.8 $1.00 2/15/20235,400 shares $2.65 thousand -64.0%0.0%0.1 $0.49 1/31/20231,080,000 shares $1.11 million -13.6%N/A0.8 $1.03 1/31/202315,000 shares $8.40 thousand +552.2%0.1%0.4 $0.56 1/15/20231,250,000 shares $1.51 million -20.9%N/A1 $1.21 1/15/20232,300 shares $1.12 thousand -85.4%0.0%0.1 $0.49 12/30/20221,580,000 shares $1.57 million +17.9%N/A1.3 $0.99 12/30/202215,800 shares $7.54 thousand +30.6%0.1%0.6 $0.48 12/15/20221,340,000 shares $1.08 million -12.4%N/A0.9 $0.81 12/15/202212,100 shares $5.81 thousand -55.0%0.1%0.4 $0.48 11/30/20221,530,000 shares $2.30 million -0.7%N/A1.3 $1.50 11/30/202226,900 shares $15.55 thousand +23.4%0.2%0.9 $0.58 11/15/20221,540,000 shares $2.93 million -4.9%N/A1.9 $1.90 11/15/202221,800 shares $13.56 thousand +46.3%0.2%0.4 $0.62 10/31/20221,620,000 shares $3.08 million -1.8%N/A1.9 $1.90 10/31/202214,900 shares $9.89 thousand -23.6%0.1%0.2 $0.66 10/15/20221,650,000 shares $3.33 million -8.8%N/A2.1 $2.02 10/15/202219,500 shares $16.38 thousand +2.6%0.2%0.2 $0.84 9/30/20221,810,000 shares $3.10 million +272.0%N/A2.4 $1.71 9/30/202219,000 shares $16.63 thousand +8.0%0.1%0.2 $0.88 9/15/2022486,600 shares $583.92 thousand -11.3%N/A1.1 $1.20 9/15/202217,600 shares $22 thousand -78.4%0.1%0.2 $1.25 8/31/2022548,700 shares $543.27 thousand -57.5%N/A1.7 $0.99 8/31/202281,500 shares $105.95 thousand +1,634.0%0.6%0.6 $1.30 8/15/20221,290,000 shares $1.88 million +92.2%N/A4.7 $1.46 8/15/20224,700 shares $6.25 thousand -35.6%0.0%0 $1.33 7/31/2022671,200 shares $859.14 thousand +13.8%4.3%3 $1.28 7/31/20227,300 shares $11.10 thousand -16.1%0.1%0 $1.52 7/15/2022590,000 shares $631.30 thousand -1.2%3.8%2.9 $1.07 7/15/20228,700 shares $11.48 thousand No Change0.1%0 $1.32 6/30/2022597,000 shares $576.11 thousand -9.4%2.7%2.9 $0.97 6/15/2022658,700 shares $744.33 thousand +0.8%3.0%3.7 $1.13 5/31/2022653,300 shares $790.49 thousand +6.3%2.9%2.7 $1.21 5/15/2022614,600 shares $737.52 thousand -0.6%2.8%1.5 $1.20 4/30/2022618,000 shares $797.22 thousand -15.9%2.9%1.5 $1.29 4/15/2022734,900 shares $1.04 million +15.7%3.4%1.8 $1.42 3/31/2022635,200 shares $1.11 million +12.9%3.0%1.6 $1.75 3/15/2022562,800 shares $1.11 million +22.1%2.9%1.2 $1.97 2/28/2022461,000 shares $691.50 thousand +29.7%2.4%0.5 $1.50 2/15/2022355,500 shares $579.47 thousand -34.5%1.8%0.4 $1.63 1/31/2022543,100 shares $1.12 million +26.0%2.6%0.6 $2.06 1/15/2022430,900 shares $900.58 thousand -38.1%2.1%0.5 $2.09A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 12/31/2021695,800 shares $1.59 million +68.2%N/A0 $2.29 12/15/2021413,600 shares $835.47 thousand +49.5%2.1%0.5 $2.02 11/30/2021276,600 shares $1.23 million +15.8%1.4%1.4 $4.45 11/15/2021238,800 shares $1.15 million -0.7%1.2%1.4 $4.83 10/29/2021240,400 shares $1.16 million -7.7%1.2%1.4 $4.84 10/15/2021260,400 shares $1.36 million +39.4%1.4%2.3 $5.23 9/30/2021186,800 shares $988.17 thousand -51.6%1.0%1.8 $5.29 9/15/2021385,800 shares $1.85 million +2.0%2.0%2.2 $4.80 8/31/2021378,300 shares $1.94 million -7.8%2.0%1.8 $5.13 8/13/2021410,300 shares $2.32 million -22.3%2.1%1.8 $5.66 7/30/2021527,800 shares $3.03 million -10.6%2.7%2.3 $5.75 7/15/2021590,400 shares $3.50 million +61.7%2.9%2.6 $5.92 6/30/2021365,100 shares $2.37 million -68.3%1.8%1.6 $6.50 6/15/20211,150,000 shares $9.32 million +25.3%5.8%7.4 $8.10 5/28/2021917,800 shares $8.72 million -3.3%4.6%7.2 $9.50 5/14/2021949,300 shares $7.07 million +19.7%N/A8.3 $7.45 4/30/2021793,300 shares $6.73 million +16.7%N/A7.2 $8.48 4/15/2021679,700 shares $6.08 million +10.7%N/A6.1 $8.95 3/31/2021614,300 shares $5.20 million +12.6%N/A5.4 $8.47 3/15/2021545,700 shares $5.21 million +16.3%N/A5 $9.55 2/26/2021469,200 shares $4.49 million +9.8%N/A4.7 $9.57 2/12/2021427,200 shares $3.81 million +14.6%N/A4.3 $8.91 1/29/2021372,700 shares $2.78 million -0.9%N/A4.2 $7.45 1/15/2021376,200 shares $3.07 million +0.6%N/A4.4 $8.15 12/31/2020374,100 shares $2.53 million +8.7%N/A4.6 $6.75 12/15/2020344,200 shares $2.09 million -3.5%N/A4.3 $6.09 11/30/2020356,600 shares $2.42 million +8.7%N/A3.8 $6.80 10/30/2020312,700 shares $1.82 million -4.9%N/A3.5 $5.83 10/15/2020328,900 shares $2.22 million +6.9%N/A3.6 $6.76 9/30/2020307,600 shares $2.08 million +6.2%N/A3.1 $6.77 9/15/2020289,700 shares $2.05 million +12.1%N/A2.9 $7.06 8/31/2020258,400 shares $2.17 million -10.7%N/A2.6 $8.38 XFOR Short Interest - Frequently Asked Questions What is X4 Pharmaceuticals' current short interest? Short interest is the volume of X4 Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 1,020,000 shares of XFOR short. 26.22% of X4 Pharmaceuticals' shares are currently sold short. Learn More on X4 Pharmaceuticals' current short interest. What is a good short interest ratio for X4 Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XFOR shares currently have a short interest ratio of 1.0. Learn More on X4 Pharmaceuticals's short interest ratio. Which institutional investors are shorting X4 Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of X4 Pharmaceuticals: Group One Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for X4 Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.22% of X4 Pharmaceuticals' floating shares are currently sold short. Is X4 Pharmaceuticals' short interest increasing or decreasing? X4 Pharmaceuticals saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,020,000 shares, an increase of 161.3% from the previous total of 390,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is X4 Pharmaceuticals' float size? X4 Pharmaceuticals currently has issued a total of 11,410,000 shares. Some of X4 Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. X4 Pharmaceuticals currently has a public float of 3,890,000 shares. How does X4 Pharmaceuticals' short interest compare to its competitors? 26.22% of X4 Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to X4 Pharmaceuticals: Immix Biopharma, Inc. (1.18%), MediciNova, Inc. (0.26%), Genenta Science S.p.A. Unsponsored ADR (0.05%), Cue Biopharma, Inc. (1.28%), Adlai Nortye Ltd. Sponsored ADR (0.01%), Gain Therapeutics, Inc. (0.74%), CEL-SCI Co. (11.25%), Werewolf Therapeutics, Inc. (2.47%), Adverum Biotechnologies, Inc. (7.13%), MiNK Therapeutics, Inc. (3.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short X4 Pharmaceuticals stock? Short selling XFOR is an investing strategy that aims to generate trading profit from X4 Pharmaceuticals as its price is falling. XFOR shares are trading up $0.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against X4 Pharmaceuticals? A short squeeze for X4 Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XFOR, which in turn drives the price of the stock up even further. How often is X4 Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XFOR, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Immix Biopharma Short Squeeze MediciNova Short Squeeze Genenta Science Short Squeeze Cue Biopharma Short Squeeze Adlai Nortye Short Squeeze Gain Therapeutics Short Squeeze CEL-SCI Short Squeeze Werewolf Therapeutics Short Squeeze Adverum Biotechnologies Short Squeeze MiNK Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XFOR) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access